share_log

NovAccess Global Inc. (OTCMKTS:XSNX) Sees Significant Decrease in Short Interest

NovAccess Global Inc. (OTCMKTS:XSNX) Sees Significant Decrease in Short Interest

NovAccess Global Inc.（OTCMKTS: XSNX）认为空头利率将大幅下降
Defense World ·  2023/02/14 16:32

NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 3,900 shares, a decline of 25.0% from the January 15th total of 5,200 shares. Based on an average trading volume of 8,000 shares, the short-interest ratio is presently 0.5 days.

NovAccess Global Inc.（OTCMKTS: XSNX — Get Rating）在1月份的空头利率大幅下降。截至1月31日，空头利率共计3,900股，较1月15日的5,200股下降了25.0％。根据8,000股的平均交易量，目前的空头利率为0.5天。

NovAccess Global Price Performance

Novaccess 全球价格表现

XSNX stock opened at $0.21 on Tuesday. NovAccess Global has a 12 month low of $0.10 and a 12 month high of $0.60. The firm has a 50 day moving average of $0.21 and a two-hundred day moving average of $0.20.

XSNX股票周二开盘价为0.21美元。NovAccess Global创下12个月低点0.10美元，12个月高点为0.60美元。该公司的50天移动平均线为0.21美元，两百天移动平均线为0.20美元。

Get
获取
NovAccess Global
NovAcces
alerts:
警报：

NovAccess Global Company Profile

NovAccess 全球公司简介

(Get Rating)

（获取评分）

NovAccess Global, Inc is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.
NovAccess Global, Inc是一家生物制药公司，从事癌症和神经系统疾病的诊断和疗法的提供，以及治疗脑肿瘤患者的免疫疗法的开发。该公司成立于1997年2月25日，总部位于俄亥俄州凯霍加县。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
  • Should Medtronic's Recent Colibri Patent Controversy Concern You?
  • Checkpoint Software Helps Cyber Security Stocks Bottom
  • Under Armour Stock, Gap and Crap, Here's Why
  • Is Chevron Positioned To Take Energy Sector Leadership?
  • What Does the Consumer Price Index Measure?
  • 免费获取 StockNews.com 关于 NovAccess Global (XSNX) 的研究报告的副本
  • 美敦力最近的Colibri专利争议是否应该引起你的关注？
  • Checkpoint 软件帮助网络安全股触底
  • Under Armour Stock、Gap and Crap，原因如下
  • 雪佛龙有望在能源领域占据领导地位吗？
  • 消费者价格指数衡量什么？

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.

接收 NovAccess 全球日报的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收NovAccess Global及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发